Acino

MBA, IMD International, Lausanne, Switzerland

Bachelor, International Business & Economic and Strategic Market Management, Copenhagen Business School, Denmark

Chief Executive Officer and Member of Group Management since 30 May, 2018

Honours Degree in Law of Leeds University, UK

Chief Financial Officer Acino Group and Member of Group Management since 1 July 2018

Degree from the Geological Academy of Russian Federation, Moscow, Russia

Head of Corporate Business Development and Member of Group Management since May 16, 2014

MBA, Cranfield School of Management, Cranfield

PhD in Organic Chemistry, University of York, York

BSc (Hons) Chemistry, University of East Anglia, Norwich

General Manager MEA and member of the Acino Executive Committee since October 1st, 2018.

Biotechnology Engineer of Institut National des Sciences Appliquées, Toulouse, France

Group HR Director and Member of Group Management since November 13, 2017

DBA degree (ongoing), International Management Institute (IMI-Kyiv)

MBA, International Management Institute (IMI-Kyiv)

PhD in cardiology, Research Institute of Therapy (Academy of Medical Science of Ukraine)

MD, Kharkiv Medical Institute, honors

Pharmaceutical doctor from the University of Clermont-Ferrand and Post Graduate Diploma in Pharmacology, Drug Development and Regulation from the Tuft Medical School in Boston, USA.

Head of Global Medical Affairs, Regulatory Affairs and Pharmacovigilance and Member of Group Management since August, 2016

German qualified lawyer, University of Passau, Passau, Germany

Chief Legal & Compliance Officer and Member of Group Management from March 16, 2015

Master of Business Administration and Bachelor of Science – Mechanical Engineering from the University of Sherbrooke in Canada.

Chief Operations Officer and Member of Group Management since February 15, 2017

Ph.D. in Neuroscience, Karolinska Institutet, Sweden

• Chairman of the Board of Acino International AG since December 17, 2013
• Current term of office on the Board expires in 2018

Håkan Björklund joined Avista Capital Partners in October 2011. Mr. Björklund is the former Chief Executive Officer of Nycomed, which was sold to Takeda Pharmaceuticals in September 2011. Under Mr. Björklund’s leadership, Nycomed grew from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia/CIS, Brazil and Latin America. Prior to Nycomed, Mr. Björklund was Regional Director at Astra (now AstraZeneca) and, earlier, President of Astra Draco. He is Chairman of the Board of Directors at Lundbeck A/S, a member of the Board of Directors of Alere Inc., Coloplast A/S and Atos Medical AB. He was also a director at Danisco A/S until its recent acquisition by Dupont.

BA, University of Virginia, USA; MBA, Harvard Business School, USA

• Member of the Board of Acino International AG since
  December 17, 2013
• Current term of office expires in 2018

Tom Dean is the Co-Managing Partner and Co-CEO of Avista Capital Partners. Prior to co-founding Avista Capital Partners in 2005, Mr. Dean led DLJ Merchant Banking Partners (“DLJMB”), serving as Co-Managing Partner of DLJMB since 1995 and Chairman of the Investment Committees of DLJMB I, DLJMB II, DLJMB III and DLJ Growth Capital Partners through December 2007. Mr. Dean currently serves on the boards of ConvaTec, Sidewinder Drilling, Zest Anchors, and VWR International. Mr. Dean formerly served as the Chairman of the board of Nycomed, Arcade, DeCrane Aircraft, Mueller and Von Hoffmann. He also formerly served on the boards of American Ref-Fuel, Argyle Television, BioPartners, Charles River Labs, Evergreen Media, Merrill, Safilo, Visant and IWCO Direct Holdings, among others.

MSc in Economics, Hanken School of Economics in Helsinki, Finland

• Member of the Board of Acino International AG since February 22, 2017
• Current term of office on the Board expires in 2018

Johan Ek, has worked as an Industrial Advisor to the Nordic Capital Funds since July 2012. Johan is currently Chairman of the Board of Sunrise Medical and Saferoad and vice Chairman of the Board of Handicare. He was previously Chairman on the board of CPS. Johan also works as an investor through his own business. Johan started his career at McKinsey & Company as a management consultant. He then joined LGP Allgon AB and served in various positions including President, and later became President of Business Unit Europe at Powerwave Technologies Inc. between 2005-2012, Johan worked as President and CEO of the Relacom Group.

MSc in Engineering from the Swedish Royal Institute of Technology and a B.A. Economics from the Stockholm University.

• Member of the Board of Acino International AG since
  April 18, 2018
• Current term of office expires in 2019

Joined NC Advisory, Advisor to the Nordic Capital funds, in January 2016. Olof is head of the Operational Team which provides operational support to portfolio companies. Olof has extensive experience in leadership roles in large industrial companies where he spent the first 20 years of his career. Since joining, Olof has been driving the Operational Excellence effort and working on establishing and developing Nordic Capital’s Operations Team. Olof is board member of several of portfolio companies. Prior to joining, his most recent positions were as CEO of two large public industrial groups, Sandvik (2011–2015) and SSAB (2006–2010).

M.A. and B.A., Cambridge University, USA
MBA, Wharton School at the University of Pennsylvania, USA

• Member of the Board of Acino International AG since December 17, 2013
• Current term of office expires in 2018

Kunal Pandit joined Avista Capital Partners in 2010. Mr. Pandit was previously at DLJ Merchant Banking Partners (“DLJMB”) in London. Prior to DLJMB, Mr. Pandit was a member of the leveraged finance group and the investment banking department at Lehman Brothers in London. He currently serves as a director of Guala Closures.

M.Sc. in Engineering Physics, Royal Institute of Technology of Stockholm, Sweden
B.Sc. in Business Administration and Economics, Stockholm University School of Business, Sweden

• Member of the Board of Acino International AG since December 17, 2013
• Current term of office expires in 2018

Thomas Vetander joined NC Advisory AB, advisor to the Nordic Capital funds, in 2006. From 2004 to 2006, Mr. Vetander worked as a Management Consultant at McKinsey & Company in Stockholm. Mr. Vetander serves on the board of Handicare and as a deputy board member of Convatec.

B.Sc. in Economics and Business Administration, University of Uppsala, Sweden; MBA, University of Wisconsin, USA

• Vice-Chairman of the Board of Acino International AG since December 17, 2013
• Current term of office expires in 2018

Toni Weitzberg joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. Prior to joining, Mr. Weitzberg held various executive positions within the Pharmacia Group, most recently as Senior Vice President and Head of Pharmacia Europe. He currently serves as a board member of Convatec and Handicare. Mr. Weitzberg is the former Chairman of Dynal, Biovitrum, Atos, Nycomed, as well as a former board member of Fougera Pharmaceuticals, Unomedical and Permobil.